Acunivive 90 Injection System and Moxetumomab Pasudotox-tdfk
Determining the interaction of Acunivive 90 Injection System and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ketorolac
Brand name: Sprix, Toradol
Synonyms: Ketorolac (nasal), Ketorolac (Nasal)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acunivive 90 Injection System-Moxetumomab pasudotox-tdfk Intravenous
- Acunivive 90 Injection System-Moxifloxacin
- Acunivive 90 Injection System-Moxifloxacin (Systemic)
- Acunivive 90 Injection System-Moxifloxacin Hydrochloride
- Acunivive 90 Injection System-Moxifloxacin Injection
- Acunivive 90 Injection System-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Acuvail
- Moxetumomab Pasudotox-tdfk-Acyclovir
- Moxetumomab Pasudotox-tdfk-Acyclovir (Systemic)
- Moxetumomab Pasudotox-tdfk-Acyclovir and Hydrocortisone
- Moxetumomab Pasudotox-tdfk-Acyclovir and hydrocortisone topical
- Moxetumomab Pasudotox-tdfk-Acyclovir and hydrocortisone Topical application